• Profile
Close

Acute kidney injury during daptomycin vs vancomycin treatment in cardiovascular critically ill patients: A propensity score matched analysis

BMC Infectious Diseases May 25, 2019

Gaudard P, et al. - In this study, researchers evaluated whether patients treated for Gram-positive cardiovascular infection with daptomycin (DAP) experience a lower incidence of acute kidney injury (AKI) vs patients treated with vancomycin (VAN), with comparable efficacy. The study sample consisted of 72 intensive care unit (ICU) patients, treated for infective endocarditis, cardiovascular foreign body infection, or surgical site infection (DAP, n=28; VAN, n=44). A lower AKI risk was noted in correlation with daptomycin vs vancomycin among ICU patients treated for cardiovascular procedure-related infection. Daptomycin could, therefore, be considered as a first-line therapy option for AKI prevention in high-risk patients, concluded the authors.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay